PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 34690521-3 2022 Through molecular docking and dynamic simulation studies, we used the FDA-approved drug mezonavir against the most important viral targets, including spike (S) glycoprotein, Transmembrane serine protease 2 (TMPRSS2), RNA-dependent RNA polymerase (RdRp), Main protease (Mpro), human angiotensin-converting enzyme 2 (ACE-2), and furin. mezonavir 88-97 transmembrane serine protease 2 Homo sapiens 174-205 34690521-3 2022 Through molecular docking and dynamic simulation studies, we used the FDA-approved drug mezonavir against the most important viral targets, including spike (S) glycoprotein, Transmembrane serine protease 2 (TMPRSS2), RNA-dependent RNA polymerase (RdRp), Main protease (Mpro), human angiotensin-converting enzyme 2 (ACE-2), and furin. mezonavir 88-97 transmembrane serine protease 2 Homo sapiens 207-214